Sleep Apnea and Stroke

Canadian Journal of Cardiology

Volumn 31, Issue 7, 2015, Pages 918-927

  Lyons, Owen D ^a   Ryan, Clodagh M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; AUTONOMIC DYSFUNCTION; BRAIN BLOOD FLOW; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; EVIDENCE BASED PRACTICE; HEALTH CARE; HEART ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; KNOWLEDGE BASE; MEDICAL SOCIETY; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATENT FORAMEN OVALE; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; POPULATION; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SLEEP DISORDERED BREATHING; SLEEP QUALITY; COMPLICATION; HEALTH; STROKE;

GLOBAL HEALTH; HUMANS; PREVALENCE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; STROKE;

EID: 84937578464     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2015.03.014     Document Type: Review

References (119)

1. Feigin V.L., Forouzanfar M.H., Krishnamurthi R., et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014, 383:245-254.
2. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397.
3. Ip H.L., Liebeskind D.S. The future of ischemic stroke: flow from prehospital neuroprotection to definitive reperfusion. Interv Neurol 2014, 2:105-117.
4. Majid A. Neuroprotection in stroke: past, present, and future. ISRN Neurol 2014, 2014:515716.
5. Aarnio K., Haapaniemi E., Melkas S., et al. Long-term mortality after first-ever and recurrent stroke in young adults. Stroke 2014, 45:2670-2676.
6. Muller J.E., Tofler G.H., Stone P.H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989, 79:733-743.
7. Marler J.R., Price T.R., Clark G.L., et al. Morning increase in onset of ischemic stroke. Stroke 1989, 20:473-476.
8. Turin T.C., Kita Y., Rumana N., et al. Morning surge in circadian periodicity of ischaemic stroke is independent of conventional risk factor status: findings from the Takashima Stroke Registry 1990-2003. Eur J Neurol 2009, 16:843-851.
9. Martinez Garcia M.A., Galiano Blancart R., Cabero Salt L., et al. Prevalence of sleep-disordered breathing in patients with acute ischemic stroke: influence of onset time of stroke. Arch Bronconeumol 2004, 40:196-202. [in Spanish].
10. Goldstein L.B., Bushnell C.D., Adams R.J., et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:517-584.
11. Allen C.L., Bayraktutan U. Risk factors for ischaemic stroke. Int J Stroke 2008, 3:105-116.
12. Kernan W.N., Ovbiagele B., Black H.R., et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014, 45:2160-2236.
13. Arzt M., Young T., Peppard P.E., et al. Dissociation of obstructive sleep apnea from hypersomnolence and obesity in patients with stroke. Stroke 2010, 41:e129-e134.
14. Srijithesh P.R., Shukla G., Srivastav A., et al. Validity of the Berlin Questionnaire in identifying obstructive sleep apnea syndrome when administered to the informants of stroke patients. J Clin Neurosci 2011, 18:340-343.
15. Kuna S.T., Gurubhagavatula I., Maislin G., et al. Noninferiority of functional outcome in ambulatory management of obstructive sleep apnea. Am J Respir Crit Care Med 2011, 183:1238-1244.
16. Duran J., Esnaola S., Rubio R., et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001, 163:685-689.
17. Johnson K.G., Johnson D.C. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med 2010, 6:131-137.
18. Shahar E., Whitney C.W., Redline S., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001, 163:19-25.
19. Arzt M., Young T., Finn L., et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005, 172:1447-1451.
20. Redline S., Yenokyan G., Gottlieb D.J., et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010, 182:269-277.
21. Yaggi H.K., Concato J., Kernan W.N., et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005, 353:2034-2041.
22. Munoz R., Duran-Cantolla J., Martinez-Vila E., et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 2006, 37:2317-2321.
23. Campos-Rodriguez F., Martinez-Garcia M.A., Reyes-Nunez N., et al. Role of sleep apnea and continuous positive airway pressure therapy in the incidence of stroke or coronary heart disease in women. Am J Respir Crit Care Med 2014, 189:1544-1550.
24. Wang X., Ouyang Y., Wang Z., et al. Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Int J Cardiol 2013, 169:207-214.
25. Kaneko Y., Hajek V.E., Zivanovic V., et al. Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep 2003, 26:293-297.
26. Rola R., Jarosz H., Wierzbicka A., et al. Sleep disorderd breathing and recurrence of cerebrovascular events, case-fatality, and functional outcome in patients with ischemic stroke or transient ischemic attack. J Physiol Pharmacol 2008, 59(suppl 6):615-621.
27. Parra O., Sanchez-Armengol A., Bonnin M., et al. Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial. Eur Respir J 2011, 37:1128-1136.
28. Yan-fang S., Yu-ping W. Sleep-disordered breathing: impact on functional outcome of ischemic stroke patients. Sleep Med 2009, 10:717-719.
29. Sahlin C., Sandberg O., Gustafson Y., et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med 2008, 168:297-301.
30. Martinez-Garcia M.A., Soler-Cataluna J.J., Ejarque-Martinez L., et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 2009, 180:36-41.
31. Martinez-Garcia M.A., Campos-Rodriguez F., Soler-Cataluna J.J., et al. Increased incidence of non-fatal cardiovascular events in stroke patients with sleep apnoea: effects of CPAP treatment. Eur Respir J 2012, 39:906-912.
32. Scala R., Turkington P.M., Wanklyn P., et al. Acceptance, effectiveness and safety of continuous positive airway pressure in acute stroke: a pilot study. Respir Med 2009, 103:59-66.
33. Ryan C.M., Bayley M., Green R., et al. Influence of continuous positive airway pressure on outcomes of rehabilitation in stroke patients with obstructive sleep apnea. Stroke 2011, 42:1062-1067.
34. Sandberg O., Franklin K.A., Bucht G., et al. Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J 2001, 18:630-634.
35. Wessendorf T.E., Wang Y.M., Thilmann A.F., et al. Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke. Eur Respir J 2001, 18:623-629.
36. Hsu C.Y., Vennelle M., Li H.Y., et al. Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry 2006, 77:1143-1149.
37. Palombini L., Guilleminault C. Stroke and treatment with nasal CPAP. Eur J Neurol 2006, 13:198-200.
38. Matthias M.S., Chumbler N.R., Bravata D.M., et al. Challenges and motivating factors related to positive airway pressure therapy for post-TIA and stroke patients. Behav Sleep Med 2014, 12:143-157.
39. Parra O., Sanchez-Armengol A., Capote F., et al. Efficacy of continuous positive airway pressure treatment on 5-year survival in patients with ischaemic stroke and obstructive sleep apnea: a randomized controlled trial. J Sleep Res 2015, 24:47-53.
40. Bravata D.M., Concato J., Fried T., et al. Continuous positive airway pressure: evaluation of a novel therapy for patients with acute ischemic stroke. Sleep 2011, 34:1271-1277.
41. Svatikova A., Chervin R.D., Wing J.J., et al. Positional therapy in ischemic stroke patients with obstructive sleep apnea. Sleep Med 2011, 12:262-266.
42. Dyken M.E., Im K.B. Obstructive sleep apnea and stroke. Chest 2009, 136:1668-1677.
43. Brown D.L., McDermott M., Mowla A., et al. Brainstem infarction and sleep-disordered breathing in the BASIC sleep apnea study. Sleep Med 2014, 15:887-891.
44. Young T., Skatrud J., Peppard P.E. Risk factors for obstructive sleep apnea in adults. JAMA 2004, 291:2013-2016.
45. Chan W., Coutts S.B., Hanly P. Sleep apnea in patients with transient ischemic attack and minor stroke: opportunity for risk reduction of recurrent stroke?. Stroke 2010, 41:2973-2975.
46. Brown D.L., Bapuraj J.R., Mukherji S.K., et al. MRI of the pharynx in ischemic stroke patients with and without obstructive sleep apnea. Sleep Med 2010, 11:540-544.
47. Bradley T.D., Floras J.S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009, 373:82-93.
48. Bålfors E.M., Franklin K.A. Impairment of cerebral perfusion during obstructive sleep apneas. Am J Respir Crit Care Med 1994, 150:1587-1591.
49. Gladstone D.J., Spring M., Dorian P., et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014, 370:2467-2477.
50. Mehra R., Benjamin E.J., Shahar E., et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 2006, 173:910-916.
51. Gami A.S., Hodge D.O., Herges R.M., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007, 49:565-571.
52. Tanigawa T., Yamagishi K., Sakurai S., et al. Arterial oxygen desaturation during sleep and atrial fibrillation. Heart 2006, 92:1854-1855.
53. Mansukhani M.P., Calvin A.D., Kolla B.P., et al. The association between atrial fibrillation and stroke in patients with obstructive sleep apnea: a population-based case-control study. Sleep Med 2013, 14:243-246.
54. Dworakowski R., Alom-Ruiz S.P., Shah A.M. NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype. Pharmacol Rep 2008, 60:21-28.
55. Lavie L. Oxidative stress in obstructive sleep apnea and intermittent hypoxia - revisited - the bad, ugly, and good: implications to the heart and brain. Sleep Med Rev 2015, 20:27-45.
56. Barcelo A., Miralles C., Barbe F., et al. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 2000, 16:644-647.
57. Foster G.E., Hanly P.J., Ahmed S.B., et al. Intermittent hypoxia increases arterial blood pressure in humans through a renin-angiotensin system-dependent mechanism. Hypertension 2010, 56:369-377.
58. Touyz R.M. Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep 2000, 2:98-105.
59. Nicholl D.D., Hanly P.J., Poulin M.J., et al. Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea. Am J Respir Crit Care Med 2014, 190:572-580.
60. Jelic S., Lederer D.J., Adams T., et al. Vascular inflammation in obesity and sleep apnea. Circulation 2010, 121:1014-1021.
61. Jelic S., Padeletti M., Kawut S.M., et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008, 117:2270-2278.
62. Patt B.T., Jarjoura D., Haddad D.N., et al. Endothelial dysfunction in the microcirculation of patients with obstructive sleep apnea. Am J Respir Crit Care Med 2010, 182:1540-1545.
63. Kaczmarek E., Bakker J.P., Clarke D.N., et al. Molecular biomarkers of vascular dysfunction in obstructive sleep apnea. PLoS One 2013, 8:e70559.
64. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995, 38:357-366.
65. Butterfield D., Castegna A., Pocernich C., et al. Nutritional approaches to combat oxidative stress in Alzheimer disease. J Nutr Biochem 2002, 13:444.
66. Wang Y., Zhang S.X., Gozal D. Reactive oxygen species and the brain in sleep apnea. Respir Physiol Neurobiol 2010, 174:307-316.
67. Nair D., Dayyat E.A., Zhang S.X., et al. Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea. PLoS One 2011, 6:e19847.
68. Chuang L.P., Chen N.H., Lin S.W., et al. Increased matrix metalloproteinases-9 after sleep in plasma and in monocytes of obstructive sleep apnea patients. Life Sci 2013, 93:220-225.
69. Heo S.H., Cho C.H., Kim H.O., et al. Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J Clin Neurol 2011, 7:69-76.
70. Mun-Bryce S., Rosenberg G.A. Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab 1998, 18:1163-1172.
71. Bektas H., Wu T.C., Kasam M., et al. Increased blood-brain barrier permeability on perfusion CT might predict malignant middle cerebral artery infarction. Stroke 2010, 41:2539-2544.
72. Medeiros C.A., de Bruin V.M., Andrade G.M., et al. Obstructive sleep apnea and biomarkers of inflammation in ischemic stroke. Acta Neurol Scand 2012, 126:17-22.
73. Polak J.F., Pencina M.J., O'Leary D.H., et al. Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. Stroke 2011, 42:3017-3021.
74. Drager L.F., Bortolotto L.A., Lorenzi M.C., et al. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005, 172:613-618.
75. Drager L.F., Bortolotto L.A., Maki-Nunes C., et al. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 2010, 208:490-495.
76. Drager L.F., Bortolotto L.A., Krieger E.M., et al. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension 2009, 53:64-69.
77. Drager L.F., Polotsky V.Y., Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 2011, 140:534-542.
78. Ali S.S., Oni E.T., Warraich H.J., et al. Systematic review on noninvasive assessment of subclinical cardiovascular disease in obstructive sleep apnea: new kid on the block!. Sleep Med Rev 2014, 18:379-391.
79. Dziewas R., Ritter M., Usta N., et al. Atherosclerosis and obstructive sleep apnea in patients with ischemic stroke. Cerebrovasc Dis 2007, 24:122-126.
80. Cereda C.W., Tamisier R., Manconi M., et al. Endothelial dysfunction and arterial stiffness in ischemic stroke: the role of sleep-disordered breathing. Stroke 2013, 44:1175-1178.
81. Nachtmann A., Stang A., Wang Y.M., et al. Association of obstructive sleep apnea and stenotic artery disease in ischemic stroke patients. Atherosclerosis 2003, 169:301-307.
82. Jackman K.A., Zhou P., Faraco G., et al. Dichotomous effects of chronic intermittent hypoxia on focal cerebral ischemic injury. Stroke 2014, 45:1460-1467.
83. Stevenson S.F., Doubal F.N., Shuler K., et al. A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 2010, 41:e434-e442.
84. Markus H., Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 2001, 124:457-467.
85. Nasr N., Traon A.P., Czosnyka M., et al. Cerebral autoregulation in patients with obstructive sleep apnea syndrome during wakefulness. Eur J Neurol 2009, 16:386-391.
86. Urbano F., Roux F., Schindler J., et al. Impaired cerebral autoregulation in obstructive sleep apnea. J Appl Physiol (1985) 2008, 105:1852-1857.
87. Lammie G.A. Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002, 12:358-370.
88. Gorelick P.B. New horizons for stroke prevention: PROGRESS and HOPE. Lancet Neurol 2002, 1:149-156.
89. Kario K., Pickering T.G., Matsuo T., et al. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001, 38:852-857.
90. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009, 338:b1665.
91. Somers V.K., Dyken M.E., Clary M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96:1897-1904.
92. Cooper V.L., Pearson S.B., Bowker C.M., et al. Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia - a mechanism for promoting hypertension in obstructive sleep apnoea. J Physiol 2005, 568:677-687.
93. Bazzano L.A., Khan Z., Reynolds K., et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007, 50:417-423.
94. Marin J.M., Agusti A., Villar I., et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012, 307:2169-2176.
95. Young T., Peppard P., Palta M., et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997, 157:1746-1752.
96. Alajmi M., Mulgrew A.T., Fox J., et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007, 185:67-72.
97. O'Connor G.T., Caffo B., Newman A.B., et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009, 179:1159-1164.
98. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378-1384.
99. Barbe F., Duran-Cantolla J., Sanchez-de-la-Torre M., et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA 2012, 307:2161-2168.
100. Turkington P.M., Bamford J., Wanklyn P., et al. Effect of upper airway obstruction on blood pressure variability after stroke. Clin Sci (Lond) 2004, 107:75-79.
101. Selic C., Siccoli M.M., Hermann D.M., et al. Blood pressure evolution after acute ischemic stroke in patients with and without sleep apnea. Stroke 2005, 36:2614-2618.
102. Horner R.L., Brooks D., Kozar L.F., et al. Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol 1995, 79:151-162.
103. Kamba M., Suto Y., Ohta Y., et al. Cerebral metabolism in sleep apnea. Evaluation by magnetic resonance spectroscopy. Am J Respir Crit Care Med 1997, 156:296-298.
104. Sander D., Winbeck K., Klingelhofer J., et al. Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke. Neurology 2001, 57:833-838.
105. Wiklund P.G., Nilsson L., Ardnor S.N., et al. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Stroke 2005, 36:1661-1665.
106. Guardiola J.J., Matheson P.J., Clavijo L.C., et al. Hypercoagulability in patients with obstructive sleep apnea. Sleep Med 2001, 2:517-523.
107. Nobili L., Schiavi G., Bozano E., et al. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 2000, 22:21-27.
108. Wessendorf T.E., Thilmann A.F., Wang Y.M., et al. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000, 162:2039-2042.
109. Phillips C.L., McEwen B.J., Morel-Kopp M.C., et al. Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study. Thorax 2012, 67:639-644.
110. Gu X., He Y., Li Z., et al. Comparison of frequencies of patent foramen ovale and thoracic aortic atherosclerosis in patients with cryptogenic ischemic stroke undergoing transesophageal echocardiography. Am J Cardiol 2011, 108:1815-1819.
111. Lau E.M., Jaijee S.K., Melehan K.L., et al. Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea. Int J Cardiol 2013, 165:35-40.
112. Beelke M., Angeli S., Del Sette M., et al. Obstructive sleep apnea can be provocative for right-to-left shunting through a patent foramen ovale. Sleep 2002, 25:856-862.
113. Guchlerner M., Kardos P., Liss-Koch E., et al. PFO and right-to-left shunting in patients with obstructive sleep apnea. J Clin Sleep Med 2012, 8:375-380.
114. Schafer H., Hasper E., Ewig S., et al. Pulmonary haemodynamics in obstructive sleep apnoea: time course and associated factors. Eur Respir J 1998, 12:679-684.
115. Hsieh S.W., Lai C.L., Liu C.K., et al. Obstructive sleep apnea linked to wake-up strokes. J Neurol 2012, 259:1433-1439.
116. Nopmaneejumruslers C., Kaneko Y., Hajek V., et al. Cheyne-Stokes respiration in stroke: relationship to hypocapnia and occult cardiac dysfunction. Am J Respir Crit Care Med 2005, 171:1048-1052.
117. Devereaux M.W., Keane J.R., Davis R.L. Automatic respiratory failure associated with infarction of the medulla. Report of two cases with pathologic study of one. Arch Neurol 1973, 29:46-52.
118. Levin B.E., Margolis G. Acute failure of automatic respirations secondary to a unilateral brainstem infarct. Ann Neurol 1977, 1:583-586.
119. Parra O., Arboix A., Bechich S., et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000, 161:375-380.